METHOTREXATE USE IN MISCELLANEOUS INFLAMMATORY DISEASES
Identifieur interne : 002880 ( Main/Exploration ); précédent : 002879; suivant : 002881METHOTREXATE USE IN MISCELLANEOUS INFLAMMATORY DISEASES
Auteurs : William S. WilkeSource :
- Rheumatic Disease Clinics of North America [ 0889-857X ] ; 1997.
English descriptors
- Teeft :
- Adult disease, Adult onset disease, Adverse effects, Alkaline phosphatase, Alternative agents, Arthritis, Arthritis rheum, Autoimmune liver disease, Azathioprine, Biliary, Biopsy, Bowel, Bowel disease, Case report, Case reports, Chronic sarcoidosis, Cirrhosis, Clin, Clin rheumatol, Colitis, Complete remission, Corticosteroid, Cutaneous, Cutaneous involvement, Cutaneous lesions, Cutaneous manifestations, Cutaneous sarcoidosis, Cutaneous vasculitis, Cyclosporine, Dermatomyositis, Early disease, Erythematosus, Gastroenterology, Histologic, Immunosuppressive therapy, Inflammation, Inflammatory, Inflammatory bowel disease, Inflammatory myopathy, Interstitial pneumonitis, Intravenous, Leukopenia, Liver biopsy, Liver enzymes, Lupus, Methotrexate, Methotrexate therapy, Methotrexate treatment, Mild disease, Multicentric, Multicentric reticulohistiocytosis, Myopathy, Myositis, Nodulosis, Oral ulcers, Partial response, Pilot study, Placebo, Placebo patients, Polymyositis, Positive response, Prednisone, Primary biliary cirrhosis, Primary sclerosing cholangitis, Randomized, Rash, Refractory, Relapsing polychondritis, Remission, Renal, Rheum, Rheumatoid, Rheumatoid arthritis, Rheumatol, Sarcoidosis, Sclerosis, Side effects, Skin score, Syndrome, System involvement, Systemic, Systemic lupus erythematosus, Systemic sclerosis, Toxicity, Ubca, Ulcerative, Ulcerative colitis, Ursodeoxycholic acid, Uveitis, Vasculitis, Wilke.
Abstract
This review of methotrexate (MTX) treatment is meant to be a descriptive and inclusive summary and to provide the reader with a ready overview of the subject. Some critical analysis of individual reports is included, but because of the large number of conditions presented and the nonuniform nature of the various reports, detailed discussions about the relative role for MTX among many treatment alternatives is beyond the scope of this article.
Url:
DOI: 10.1016/S0889-857X(05)70364-1
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000D54
- to stream Istex, to step Curation: 000D54
- to stream Istex, to step Checkpoint: 001673
- to stream Main, to step Merge: 002929
- to stream Main, to step Curation: 002880
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>METHOTREXATE USE IN MISCELLANEOUS INFLAMMATORY DISEASES</title><author><name sortKey="Wilke, William S" sort="Wilke, William S" uniqKey="Wilke W" first="William S." last="Wilke">William S. Wilke</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:245F6EE7A77C2277C5E1F41EA4F3187E1B2C71D3</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1016/S0889-857X(05)70364-1</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-RZ6H8T5D-T/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000D54</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000D54</idno><idno type="wicri:Area/Istex/Curation">000D54</idno><idno type="wicri:Area/Istex/Checkpoint">001673</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001673</idno><idno type="wicri:doubleKey">0889-857X:1997:Wilke W:methotrexate:use:in</idno><idno type="wicri:Area/Main/Merge">002929</idno><idno type="wicri:Area/Main/Curation">002880</idno><idno type="wicri:Area/Main/Exploration">002880</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">METHOTREXATE USE IN MISCELLANEOUS INFLAMMATORY DISEASES</title><author><name sortKey="Wilke, William S" sort="Wilke, William S" uniqKey="Wilke W" first="William S." last="Wilke">William S. Wilke</name></author></analytic><monogr></monogr><series><title level="j">Rheumatic Disease Clinics of North America</title><title level="j" type="abbrev">RDC</title><idno type="ISSN">0889-857X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1997">1997</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="855">855</biblScope><biblScope unit="page" to="882">882</biblScope></imprint><idno type="ISSN">0889-857X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0889-857X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adult disease</term><term>Adult onset disease</term><term>Adverse effects</term><term>Alkaline phosphatase</term><term>Alternative agents</term><term>Arthritis</term><term>Arthritis rheum</term><term>Autoimmune liver disease</term><term>Azathioprine</term><term>Biliary</term><term>Biopsy</term><term>Bowel</term><term>Bowel disease</term><term>Case report</term><term>Case reports</term><term>Chronic sarcoidosis</term><term>Cirrhosis</term><term>Clin</term><term>Clin rheumatol</term><term>Colitis</term><term>Complete remission</term><term>Corticosteroid</term><term>Cutaneous</term><term>Cutaneous involvement</term><term>Cutaneous lesions</term><term>Cutaneous manifestations</term><term>Cutaneous sarcoidosis</term><term>Cutaneous vasculitis</term><term>Cyclosporine</term><term>Dermatomyositis</term><term>Early disease</term><term>Erythematosus</term><term>Gastroenterology</term><term>Histologic</term><term>Immunosuppressive therapy</term><term>Inflammation</term><term>Inflammatory</term><term>Inflammatory bowel disease</term><term>Inflammatory myopathy</term><term>Interstitial pneumonitis</term><term>Intravenous</term><term>Leukopenia</term><term>Liver biopsy</term><term>Liver enzymes</term><term>Lupus</term><term>Methotrexate</term><term>Methotrexate therapy</term><term>Methotrexate treatment</term><term>Mild disease</term><term>Multicentric</term><term>Multicentric reticulohistiocytosis</term><term>Myopathy</term><term>Myositis</term><term>Nodulosis</term><term>Oral ulcers</term><term>Partial response</term><term>Pilot study</term><term>Placebo</term><term>Placebo patients</term><term>Polymyositis</term><term>Positive response</term><term>Prednisone</term><term>Primary biliary cirrhosis</term><term>Primary sclerosing cholangitis</term><term>Randomized</term><term>Rash</term><term>Refractory</term><term>Relapsing polychondritis</term><term>Remission</term><term>Renal</term><term>Rheum</term><term>Rheumatoid</term><term>Rheumatoid arthritis</term><term>Rheumatol</term><term>Sarcoidosis</term><term>Sclerosis</term><term>Side effects</term><term>Skin score</term><term>Syndrome</term><term>System involvement</term><term>Systemic</term><term>Systemic lupus erythematosus</term><term>Systemic sclerosis</term><term>Toxicity</term><term>Ubca</term><term>Ulcerative</term><term>Ulcerative colitis</term><term>Ursodeoxycholic acid</term><term>Uveitis</term><term>Vasculitis</term><term>Wilke</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">This review of methotrexate (MTX) treatment is meant to be a descriptive and inclusive summary and to provide the reader with a ready overview of the subject. Some critical analysis of individual reports is included, but because of the large number of conditions presented and the nonuniform nature of the various reports, detailed discussions about the relative role for MTX among many treatment alternatives is beyond the scope of this article.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Wilke, William S" sort="Wilke, William S" uniqKey="Wilke W" first="William S." last="Wilke">William S. Wilke</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002880 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002880 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:245F6EE7A77C2277C5E1F41EA4F3187E1B2C71D3
|texte= METHOTREXATE USE IN MISCELLANEOUS INFLAMMATORY DISEASES
}}
| This area was generated with Dilib version V0.6.33. |  |